Business Wire Feed
New Milestone of Hepatitis C Elimination: Taiwan Achieves WHO Goal Ahead of Schedule
TAIPEI, Taiwan--(BUSINESS WIRE)--Taiwan has achieved the World Health Organization’s (WHO) goal of eliminating Hepatitis C by 2025, reaching this milestone ahead of the global timeline. Through cross-sectoral collaboration from central to local levels, the nation more...
Future Forward Labs Appoints Dr. Delia DeBuc as Applied Science Mentor to Advance Applied Physics and Biomedical Innovation
SEATTLE--(BUSINESS WIRE)--#highschool--Future Forward Labs today announced the appointment of Dr. Delia DeBuc as STEM Mentor – Applied Physics and Biomedical Science. Dr. DeBuc brings more than 20 years of multidisciplinary research, scientific leadership, and STEM more...
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases. Collaboration supports Indonesian Government’s agenda to enhance diagnostic access and build more...
New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis
Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of action and improvement of itch and more...
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials showing significantly lower rate of annualized asthma exacerbations in more...
insitro Validates AI-Enabled POSH Platform in Nature Communications, Bridging Critical Gap in Drug Discovery
New publication demonstrates that insitro’s POSH platform — integrating pooled CRISPR screening and self-supervised deep learning — successfully breaks the historic compromise between scale and depth to more rapidly identify novel therapeutic targets SOUTH SAN more...
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at more...
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
– Vir Biotechnology to receive EUR 55 million initial reimbursement payment upon closing, and up to EUR 495 million in clinical, regulatory and sales milestones, along with tiered, mid-teen to high-twenties percent royalties on net more...
Two of 18 CMS-Covered Skin Substitute Products are Medical-Fish-Skin Grafts from Kerecis
Inclusion Among 18 Covered Products Makes Kerecis an Easy Partner for Providers ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--#kerecis--Kerecis, the company pioneering the use of sustainably sourced fish-skin in cellular therapy and tissue regeneration, welcomes the more...
Hospital for Special Surgery Again Receives Nation’s Highest Honor for Nursing Excellence
First New York State Hospital to Be Awarded Magnet Recognition Six Times NEW YORK--(BUSINESS WIRE)--For an astounding sixth time, Hospital for Special Surgery (HSS) has earned the nation’s top honor for nursing excellence from the more...
Neuranics Selected for Scale Up Scotland 2.0 Ahead of the Next Phase of Growth
GLASGOW, Scotland--(BUSINESS WIRE)--Following a breakthrough year of technical progress and global recognition, Neuranics has been selected to take part in the 2026 Scale Up Scotland 2.0 programme, founded by Scottish entrepreneur and philanthropist Sir Tom more...
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth
BORDEAUX, France--(BUSINESS WIRE)--#CellTherapyForAll--TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive more...
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
Execution of a 15-year contract including an option to renew with UK Nuclear Decommissioning Authority for access to up to 400 tonnes of reprocessed uranium (RepU), with the potential to deliver tens of thousands of more...
A New Era of Physical AI Senior & Dementia Care
Wonderful Platform to Introduce Avadin™, the World’s First Physical AI Care OS, at CES 2026 SAN JOSE, Calif.--(BUSINESS WIRE)--Wonderful Platform, a global leader in AI-enabled aging and dementia-care innovation, today announced the U.S. launch of more...
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
SINGAPORE--(BUSINESS WIRE)--Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP more...
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has extended more...
Washington Launches New Tools to Help Medical Professionals Deliver Life-saving Medications for Opioid Use Disorder
The Health Care Authority (HCA) and Department of Health (DOH) are equipping health care providers and emergency medical services (EMS) personnel with practical, research-based resources to expand treatment access and reduce overdose deaths. OLYMPIA, Wash.--(BUSINESS more...
GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience
Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million non-refundable upfront payment, a $50M near-term development milestone and further more...
Cizzle Brands Corporation Releases its Fiscal Q1 2026 Results
TORONTO--(BUSINESS WIRE)--Cizzle Brands Corporation (Cboe Canada: CZZL; OTCQB: CZZLF; Frankfurt: 8YF) (“Cizzle Brands” or the “Company”), a sports nutrition company that is elevating the game in health and wellness, today announced its financial results for more...
Hercules Pharmaceuticals Appoints Ali Ahmed as Chief Commercial Officer
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Hercules Pharmaceuticals today announced the appointment of Ali Ahmed as Executive Vice President, Chief Commercial Officer. Ahmed will lead commercial strategy, enterprise growth, and strategic partnerships as Hercules scales its national platform more...
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe
ATHENS, Greece--(BUSINESS WIRE)-- ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces more...
LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo® to EMA
LEO Pharma has submitted a label expansion application to EMA to expand Anzupgo® (delgocitinib) cream to adolescent patients (12–17 years) with moderate to severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or more...
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
Company to host webcast Monday, December 15, 2025 at 8:30 a.m. ET BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the company will more...
SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares
Strategic acquisition strengthens SBC's comprehensive service offerings and R&D capabilities TOKYO--(BUSINESS WIRE)--#Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services for medical organizations, more...
UnitedHealth Group Announces Earnings Release Date
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its full year 2025 financial results and provide 2026 financial guidance on Tuesday, January 27, 2026, before the market opens, and will host a teleconference at 8:00 a.m. more...